KIMBERLY ROALDI: Open Payments
NPI 1841940970 · BOWMANSVILLE, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$852 in 44 payments from 18 companies in 2025. Trend: 2023 $1,411 · 2024 $1,672 · 2025 $852
Food & beverage: $852
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 9 | $141 |
| Lilly USA, LLC | 6 | $120 |
| AstraZeneca Pharmaceuticals LP | 4 | $69 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 3 | $60 |
| Insulet Corporation | 2 | $51 |
| Sumitomo Pharma America, Inc. | 2 | $49 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 2 | $48 |
| Amgen Inc. | 3 | $47 |
| Exact Sciences Corporation | 2 | $43 |
| Otsuka America Pharmaceutical, Inc. | 2 | $41 |
Products named: MOUNJARO, JARDIANCE, Omnipod, GEMTESA, CAPLYTA, OTEZLA, Cologuard Collection Kit, REXULTI.
Industry payments across NY — which companies pay providers there.
